These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4990962)

  • 21. Response of plasma histaminase activity to small doses of heparin in normal subjects and patients with hyperlipoproteinemia.
    Baylin SB; Beaven MA; Krauss RM; Keiser HR
    J Clin Invest; 1973 Aug; 52(8):1985-93. PubMed ID: 4198195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels of histaminase and L-DOPA decarboxylase activity in the transition from C-cell hyperplasia to familial medullary thyroid carcinoma.
    Baylin SB; Mendelsohn G; Weisburger WR; Gann DS; Eggleston JC
    Cancer; 1979 Oct; 44(4):1315-21. PubMed ID: 115572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications.
    Baylin SB; Weisburger WR; Eggleston JC; Mendelsohn G; Beaven MA; Abeloff MD; Ettinger DS
    N Engl J Med; 1978 Jul; 299(3):105-10. PubMed ID: 26872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of histaminase in human tumor tissues. An immunohistochemical study.
    Nishiyama T; Hayashi I; Inoue I; Lin CW; Akagi G; Sano T
    Oncodev Biol Med; 1983; 4(3):197-207. PubMed ID: 6402766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin and histaminase in C-cell hyperplasia and medullary thyroid carcinoma. A light microscopic and immunohistochemical study.
    Mendelsohn G; Eggleston JC; Weisburger WR; Gann DS; Baylin SB
    Am J Pathol; 1978 Jul; 92(1):35-52. PubMed ID: 99045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small cell carcinoma of the lung: serum calcitonin and serum histaminase (diamine oxidase) at basal levels and stimulated by pentagastrin.
    Hansen M; Hansen HH; Tryding N
    Acta Med Scand; 1978; 204(4):257-61. PubMed ID: 211804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medullary cancer of the thyroid and hyperthyrocalcitonin syndrome].
    Milhaud G; Coutris G; Tubiana M
    Presse Med (1893); 1969 Dec; 77(56):2129-32. PubMed ID: 5374252
    [No Abstract]   [Full Text] [Related]  

  • 28. [Humoral markers in thyroid carcinoma].
    Pinchera A; Pacini F; Martino E; Anelli S
    Minerva Med; 1986 Nov; 77(44):2089-91. PubMed ID: 3785723
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical, biochemical and radiological aspects of medullary carcinoma of the thyroid.
    Sachdev Y; Hall R
    J Assoc Physicians India; 1977 Apr; 25(4):241-8. PubMed ID: 410776
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic dependability of calcitonin assay in family studies for medullary thyroid carcinoma.
    Jackson CE; Tashjian AH; Block MA
    J Lab Clin Med; 1971 Nov; 78(5):817-8. PubMed ID: 5128860
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid.
    Anast C; David L; Winnacker J; Glass R; Baskin W; Brubaker L; Burns T
    J Clin Invest; 1975 Dec; 56(6):1615-21. PubMed ID: 1202087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcitonin gene peptides: the diagnostic value of measurement in medullary thyroid carcinoma.
    Girgis SI; Lynch C; Hillyard CJ; Stevenson JC; Hill PA; MacDonald DW; MacIntyre I
    Henry Ford Hosp Med J; 1987; 35(2-3):118-9. PubMed ID: 3500936
    [No Abstract]   [Full Text] [Related]  

  • 33. The diagnosis and therapy of medullary thyroid carcinoma in childhood.
    Bindewald H; Raue F; Merkle P
    Prog Pediatr Surg; 1983; 16():43-6. PubMed ID: 6878728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radioimmunological determination of calcitonin in monitoring medullary carcinoma of the thyroid].
    Trucchi M; Marchisio M; Roncallo F; Schenone F; Santaniello B
    Arch Maragliano Patol Clin; 1980; 36():25-30. PubMed ID: 6896418
    [No Abstract]   [Full Text] [Related]  

  • 35. Hormonal dependent anaplastic thyroid carcinoma: a case report.
    Macgregor CA; Ham DP
    Surgery; 1972 Jan; 71(1):56-9. PubMed ID: 5007586
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland].
    Krassowski J; Słowińska-Srzednicka J; Gietka M; Sawicki A; Kokot F; Zgliczyński S
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):757-9. PubMed ID: 2641802
    [No Abstract]   [Full Text] [Related]  

  • 37. Serial serum calcitonin concentrations to evaluate response to therapy of patients with medullary thyroid carcinoma.
    Athanassiades P; Piperingos G; Pandos P; Koutras D; Moulopoulos S
    Chemioterapia; 1988 Jun; 7(3):195-7. PubMed ID: 3168076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medullary thyroid carcinoma: report of two cases, clinicopathological aspects and its management. Serum calcitonin determination is diagnostic.
    Angeles FS; Catanzaro FP; DiSimone AA
    R I Med J (1976); 1977 Jun; 60(6):289-92, 321. PubMed ID: 267285
    [No Abstract]   [Full Text] [Related]  

  • 39. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
    Surg Forum; 1979; 30():120-1. PubMed ID: 395674
    [No Abstract]   [Full Text] [Related]  

  • 40. Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid.
    Sisson JC; Gross MD; Frietas JE; Jackson CE; England BG
    Henry Ford Hosp Med J; 1981; 29(2):75-80. PubMed ID: 7263287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.